NASDAQ : IRTC
iRhythm Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 123.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.07B |
| Enterprise Value | 4.20B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 32.96M |
| Shares Outstanding | 32.96M |
| Shares Change (YoY) | +2.89% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 1.50% |
| Owned by Institutions (%) | 100.14% |
| Float | 30.29M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 303.05 |
| PS Ratio | 4.93 |
| Forward PS | 4.24 |
| PB Ratio | 21.85 |
| P/TBV Ratio | 21.97 |
| P/FCF Ratio | 104.33 |
| P/OCF Ratio | 47.29 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 5.09 |
| EV / EBITDA | 237.51 |
| EV / EBIT | 392.63 |
| EV / FCF | 107.82 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.85 |
| Quick Ratio | 3.65 |
| Debt / Equity | 3.91 |
| Debt / EBITDA | 24.37 |
| Debt / FCF | 18.66 |
| Interest Coverage | 0.81 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.63% |
| Return on Assets (ROA) | 0.65% |
| Return on Invested Capital (ROIC) | 0.76% |
| Return on Capital Employed (ROCE) | 1.19% |
| Weighted Average Cost of Capital (WACC) | 10.61% |
| Revenue Per Employee | $343,890 |
| Profits Per Employee | -$5,811 |
| Employee Count | 2,400 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 11.52 |
Taxes
| Measure | Value |
|---|
| Income Tax | 971,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -33.42% |
| 50-Day Moving Average | 115.04 |
| 200-Day Moving Average | 122.38 |
| Relative Strength Index (RSI) | 63.18 |
| Average Volume (20 Days) | 493,879 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.10M |
| Short Previous Month | 3.03M |
| Short % of Shares Out | 9.39% |
| Short % of Float | 10.22% |
| Short Ratio (days to cover) | 6.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 825.34M |
| Gross Profit | 589.74M |
| Operating Income | 10.70M |
| Pretax Income | -12.98M |
| Net Income | -13.95M |
| EBITDA | 17.70M |
| EBIT | 10.70M |
| Loss Per Share | -$0.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 591.27M |
| Total Debt | 727.35M |
| Net Cash | -136.08M |
| Net Cash Per Share | -$4.13 |
| Equity (Book Value) | 185.98M |
| Book Value Per Share | 5.65 |
| Working Capital | 559.86M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 86.00M |
| Capital Expenditures | -47.02M |
| Depreciation & Amortization | 6.99M |
| Net Borrowing | -3,000 |
| Free Cash Flow | 38.98M |
| FCF Per Share | $1.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.45% |
| Operating Margin | 1.30% |
| Pretax Margin | -1.57% |
| Profit Margin | -1.69% |
| EBITDA Margin | 2.14% |
| EBIT Margin | 1.30% |
| FCF Margin | 4.72% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.89% |
| Shareholder Yield | -2.89% |
| Earnings Yield | -0.35% |
| FCF Yield | 0.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $171.33 |
| Price Target Difference | 38.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 17.03% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |